NCT06048185 Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05956626 A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05904444 The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies Status COMPLETED Phase NA
NCT05674058 Function and Imaging Assessments for G1961E-associated Stargardt Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05417126 Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease Status COMPLETED Phase PHASE2
NCT05266014 This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease Status COMPLETED Phase PHASE1/PHASE2
NCT04909398 Pupil Dynamics and Color Vision for the Detection of Eye Diseases Status COMPLETED Phase NA
NCT04239625 Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03033108 Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease Status COMPLETED Phase PHASE2
NCT02875704 Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy Status TERMINATED Phase N/A
NCT02410122 The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy Status COMPLETED Phase N/A
NCT02402660 Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease Status ENROLLING_BY_INVITATION Phase PHASE2
NCT01977846 A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies Status COMPLETED Phase N/A
NCT01676766 Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease Status TERMINATED Phase N/A